Description
Research compound for the study of GLP-1 and glucagon receptor signaling interactions in metabolic pathway research models. Dual receptor agonist class targeting GLP-1R and GCGR subtypes (IBI362). Examined in controlled in vitro conditions for its comparative receptor binding profiles and downstream cAMP signaling responses relative to single-receptor agonist reference compounds.
